Go Pro
NASDAQ:BSEM

Biostem Technologies (BSEM) Stock Price, News & Analysis

$3.60 -0.08 (-2.17%)
As of 02:02 PM Eastern

About Biostem Technologies Stock (NASDAQ:BSEM)

Advanced

Key Stats

Today's Range
$3.50
$3.80
50-Day Range
N/A
52-Week Range
$2.25
$8.40
Volume
51,143 shs
Average Volume
84,442 shs
Market Capitalization
$64.26 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Sell

Company Overview

BioStem Technologies, Inc. (NASDAQ: BSEM) is a biotechnology company focused on regenerative medicine and biologic tissue products. Through its operating businesses, the company develops, manufactures and distributes human tissue allografts intended to support wound care, surgical procedures and other regenerative applications.

Its product portfolio includes placental-tissue-based products, including amniotic membrane and related graft technologies. These products are designed for use by health-care professionals in applications such as wound management and tissue repair. BioStem emphasizes the processing and preservation of donated biologic tissues for use in clinical settings.

The company is based in Florida and serves the U.S. health-care market through relationships with medical providers, distributors and other health-care organizations. BioStem Technologies is led by Chief Executive Officer Jason Matuszewski. Additional information about the company’s historical operations and geographic reach is limited, and product availability and indications may vary by applicable regulatory requirements.

AI Generated. May Contain Errors.

Receive BSEM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Biostem Technologies and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

BSEM Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com

BSEM Stock Analysis - Frequently Asked Questions

Biostem Technologies' stock was trading at $3.9090 at the beginning of 2026. Since then, BSEM shares have decreased by 7.4% and is now trading at $3.62.

Shares of BSEM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
N/A
Industry
N/A
Sub-Industry
N/A
Current Symbol
NASDAQ:BSEM
CIK
1658678
Web
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
$292.21 million
Price / Sales
0.22
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
17,849,000
Free Float
N/A
Market Cap
$64.61 million
Optionable
N/A
Beta
0.11
7 Stocks to Buy And Hold Forever Cover

Click the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

This page (NASDAQ:BSEM) was last updated on 8/21/2026 by MarketBeat.com Staff.
From Our Partners